7. Wise R. The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia. J Antimicrob Chemother. 1993;31(Suppl. A):97-104.
8.
8. Kuye O, Teal J, DeVries VG, et al. Safety profile of piperacillin/tazobactam in phase I and III clinical studies. JAntimicrob Chemother. 1993;31 (Suppl. A):113-124.
9.
9. Dickinson GM, Droller DG, Greenman RL, et al. Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid. Antimicrob Agents Chemother. 1981;20:481-486.
10.
10. Eng RH, Munsif AN, Yangco BG, et al. Seizure propensity with imipenem. Arch Intern Med. 1989;149:1881-1883.
11.
11. Malone JD, Lebar RD, Hilder R. Procaine-induced seizures after intramuscular procaine penicillin G. Mil Med. 1988;153:191-192.
12.
12. Asensi F, Otero MC, Perez-Tamarit D, et al. Risk/benefit in the treatment of children with imipenem-cilastin for meningitis caused by penicillin-resistant pneumococcus.JChemother. 1993; 5:133-134.
13.
13. Keskin S, Konkol RJ. Seizure exacerbation related to beta-lactam antibiotics in a child with cerebral dysgene-sis.Dev Med Child Neurol. 1993;35:267-274.
14.
14. Wong VK, Wright HTJr, Ross LA, et al. Imipenem/cilastin treatment of bacterial meningitis in children. Pediatr InfectDisj1991;10:122-125.
15.
15. Jalbert EO. Seizures after penicillin administration [letter]. AmJDis Child. 1985;139:1075-1075.
16.
16. Silber TJ, D'Angelo L. Psychosis and seizures following the injection of penicillin G procaine. Hoigne's syndrome. AmJDis Child. 1985;139:335-337.
17.
17. Reid KH, Shields CB, Raff MJ, et al. Effect of the topical application of some newer antibiotics on the cerebral cortex. Neurosurgery. 1987;20:868-870.
18.
18. De Sarro A, Ammendola D, Zappala M, et al. Relationship between structure and convulsant properties of some f-lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother. 1995;39:232-237.
19.
19. Kellaway P. Sleep and epilepsy. Epilepsia. 1985;26(Suppl. 1):S15-S30.
20.
20. Norrby SR. Problems in evaluation of adverse reactions to,B-lactam antibiotics. Rev Infect Dis. 1986;8(Suppl. 3): S358-S370.